|
Unusual protein modification involved in muscular dystrophy, cancer
With the discovery of a new type of chemical modification on an important muscle protein, a University of Iowa study improves understanding of certain muscular dystrophies and could potentially lead to new treatments for the conditions.
more
Scripps Florida scientists show 'lifeless' prions capable of evolutionary change and adaptation
Scientists from The Scripps Research Institute have determined for the first time that prions, bits of infectious protein devoid of DNA or RNA that can cause fatal neurodegenerative disease, are capable of Darwinian evolution. more
Carbon nanotubes show promise for high-speed genetic sequencing
Faster sequencing of DNA holds enormous potential for biology and medicine, particularly for personalized diagnosis and customized treatment based on each individual's genomic makeup. At present however, sequencing technology remains cumbersome and cost prohibitive for most clinical applications, though this may be changing, thanks to a range of innovative new techniques. more
Chronic sinusitis patients experience improved quality of life after endoscopic sinus surgery
Upwards of 76 percent of patients with chronic rhinosinusitis (CRS) experienced significant quality of life (QOL) improvements after undergoing endoscopic sinus surgery (ESS), according to new research in the January 2010 issue of Otolaryngology – Head and Neck Surgery. more
Children more likely to catch swine flu, says new research
Young people aged under 18 years are more likely than adults to catch swine flu from an infected person in their household, according to a new study published today in the New England Journal of Medicine. However, the research also shows that young people are no more likely than adults to infect others with the pandemic H1N1 virus.
more
Trial suggests new first-line treatment option for slow-growing lymphomas
Results from a phase III clinical trial conducted in Germany suggest that the standard initial treatment for patients with slow developing (or indolent) types of B-cell lymphoma should be changed. more
Use of levonorgestrel-releasing intrauterine system safe and effective after five years
Women who have a popular levonorgestrel-releasing intrauterine device removed after several years can immediately have another one inserted if they wish, according to a report from Finland.
more
© RAmEx Ars Medica,Inc. All rights reserved.
Information appearing on the Vidyya Medical News Service is not intended as a substitute for professional medical care. Seek professional medical help and follow your health care provider's advice.
Interested in subscribing to our daily e-mail newsletter? Send an email to Vidyya@Ramex.com with the word subscribe in the subject field.
|